Contineum’s Phase 2 MOONLIGHT-1 Trial Of JNJ-5120/PIPE-307 Did Not Meet Its Primary Efficacy Endpoint; Analyses Of The Data, Including Prespecified Exploratory Endpoints, Are Ongoing
In brief
The MOONLIGHT‑1 trial did not meet its main goal, raising questions about JNJ‑5120/PIPE‑307’s clinical promise.